➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Express Scripts
Mallinckrodt
Moodys
McKinsey

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

CAPTOPRIL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Captopril, and when can generic versions of Captopril launch?

Captopril is a drug marketed by Ajanta Pharma Ltd, Annora Pharma, Apothecon, Boscogen, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan, Oxford Pharms, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Vintage Pharms Llc. and is included in thirty NDAs.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Drug patent expirations by year for CAPTOPRIL
Drug Prices for CAPTOPRIL

See drug prices for CAPTOPRIL

Recent Clinical Trials for CAPTOPRIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of ParaíbaPhase 4
Case Comprehensive Cancer CenterPhase 1/Phase 2
Kafrelsheikh UniversityPhase 2

See all CAPTOPRIL clinical trials

Pharmacology for CAPTOPRIL
Medical Subject Heading (MeSH) Categories for CAPTOPRIL
Paragraph IV (Patent) Challenges for CAPTOPRIL
Tradename Dosage Ingredient NDA Submissiondate
CAPOTEN TABLET;ORAL captopril 018343

US Patents and Regulatory Information for CAPTOPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Seton Pharms CAPTOPRIL captopril TABLET;ORAL 212223-004 Oct 30, 2019 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Cosette CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-001 Dec 29, 1997 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-001 Feb 13, 1996 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Dava Pharms Inc CAPTOPRIL captopril TABLET;ORAL 074423-004 Feb 13, 1996 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Watson Labs CAPTOPRIL captopril TABLET;ORAL 074386-004 May 23, 1996 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Moodys
Baxter
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.